| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | voltage-gated sodium channel activity | 1.52e-06 | 26 | 155 | 5 | GO:0005248 | |
| GeneOntologyMolecularFunction | alkali metal ion binding | 1.52e-06 | 26 | 155 | 5 | GO:0031420 | |
| GeneOntologyMolecularFunction | sodium channel activity | 3.01e-06 | 52 | 155 | 6 | GO:0005272 | |
| GeneOntologyMolecularFunction | sodium ion binding | 3.29e-06 | 14 | 155 | 4 | GO:0031402 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | ABCC4 ABCA3 RASA1 MYO5B MYO9B CHD1 EEF1A1 EEF1A1P5 EEF1A2 RAB36 GNA14 RUVBL1 GNB5 ATP13A3 GNB3 DDX39A SNRNP200 AQR | 3.35e-05 | 775 | 155 | 18 | GO:0017111 |
| GeneOntologyMolecularFunction | signaling receptor complex adaptor activity | 6.15e-05 | 54 | 155 | 5 | GO:0030159 | |
| GeneOntologyMolecularFunction | receptor tyrosine kinase binding | 7.22e-05 | 90 | 155 | 6 | GO:0030971 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | ABCC4 ABCA3 RASA1 MYO5B MYO9B CHD1 EEF1A1 EEF1A1P5 EEF1A2 RAB36 GNA14 RUVBL1 GNB5 ATP13A3 GNB3 DDX39A SNRNP200 AQR | 9.28e-05 | 839 | 155 | 18 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | ABCC4 ABCA3 RASA1 MYO5B MYO9B CHD1 EEF1A1 EEF1A1P5 EEF1A2 RAB36 GNA14 RUVBL1 GNB5 ATP13A3 GNB3 DDX39A SNRNP200 AQR | 9.42e-05 | 840 | 155 | 18 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | ABCC4 ABCA3 RASA1 MYO5B MYO9B CHD1 EEF1A1 EEF1A1P5 EEF1A2 RAB36 GNA14 RUVBL1 GNB5 ATP13A3 GNB3 DDX39A SNRNP200 AQR | 9.42e-05 | 840 | 155 | 18 | GO:0016818 |
| GeneOntologyMolecularFunction | microfilament motor activity | 2.10e-04 | 38 | 155 | 4 | GO:0000146 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential | 2.88e-04 | 17 | 155 | 3 | GO:0099508 | |
| GeneOntologyMolecularFunction | actin filament binding | 4.05e-04 | 227 | 155 | 8 | GO:0051015 | |
| GeneOntologyMolecularFunction | protein kinase binding | RASA1 DUSP1 SHC4 SORBS1 ARHGEF16 EEF1A1 EEF1A2 TRIM43B KSR1 KAT2B PTPN14 TELO2 PRDX3 SCN5A LRP4 EIF3A TRIM48 | 4.53e-04 | 873 | 155 | 17 | GO:0019901 |
| GeneOntologyMolecularFunction | translation elongation factor activity | 4.75e-04 | 20 | 155 | 3 | GO:0003746 | |
| GeneOntologyMolecularFunction | signaling adaptor activity | 5.15e-04 | 129 | 155 | 6 | GO:0035591 | |
| GeneOntologyMolecularFunction | kinase binding | RASA1 DUSP1 SHC4 SORBS1 ARHGEF16 EEF1A1 EEF1A2 TRIM43B KSR1 KAT2B PTPN14 TELO2 PRDX3 SCN5A LRP4 PPP1R9B EIF3A TRIM48 | 5.36e-04 | 969 | 155 | 18 | GO:0019900 |
| GeneOntologyMolecularFunction | ATP-dependent activity | ABCC4 ABCA3 MYO5B MYO7A MYO7B MYO9B CHD1 ACSF2 RUVBL1 ATP13A3 DDX39A SNRNP200 AQR | 1.02e-03 | 614 | 155 | 13 | GO:0140657 |
| GeneOntologyMolecularFunction | protein tyrosine kinase binding | 1.10e-03 | 149 | 155 | 6 | GO:1990782 | |
| GeneOntologyMolecularFunction | thioredoxin-dependent peroxiredoxin activity | 1.23e-03 | 7 | 155 | 2 | GO:0140824 | |
| GeneOntologyMolecularFunction | thioredoxin peroxidase activity | 1.23e-03 | 7 | 155 | 2 | GO:0008379 | |
| GeneOntologyMolecularFunction | actin binding | MYO5B MYO7A MYO7B MYO9B CORO1C SORBS1 VILL DAAM2 PPP1R9B CTNNA1 CROCC | 1.32e-03 | 479 | 155 | 11 | GO:0003779 |
| GeneOntologyBiologicalProcess | actin filament-based movement | 2.53e-06 | 153 | 156 | 9 | GO:0030048 | |
| GeneOntologyBiologicalProcess | membrane depolarization during action potential | 7.24e-06 | 36 | 156 | 5 | GO:0086010 | |
| GeneOntologyCellularComponent | voltage-gated sodium channel complex | 1.25e-07 | 17 | 156 | 5 | GO:0001518 | |
| GeneOntologyCellularComponent | sodium channel complex | 2.23e-06 | 29 | 156 | 5 | GO:0034706 | |
| GeneOntologyCellularComponent | flotillin complex | 4.71e-05 | 10 | 156 | 3 | GO:0016600 | |
| GeneOntologyCellularComponent | axon initial segment | 6.13e-05 | 29 | 156 | 4 | GO:0043194 | |
| GeneOntologyCellularComponent | actin cytoskeleton | MYO5B MYO7A MYO7B MYO9B CORO1C SORBS1 KEAP1 EEF1A1 ACTR1A KAT2B VILL PPP1R9B CTNNA1 CROCC | 1.10e-04 | 576 | 156 | 14 | GO:0015629 |
| GeneOntologyCellularComponent | eukaryotic translation elongation factor 1 complex | 3.29e-04 | 4 | 156 | 2 | GO:0005853 | |
| GeneOntologyCellularComponent | node of Ranvier | 4.23e-04 | 20 | 156 | 3 | GO:0033268 | |
| GeneOntologyCellularComponent | cell cortex | MYO5B MYO7A MYO9B CORO1C FRYL EEF1A1 ACTR1A NSMF RASAL3 PPP1R9B | 4.86e-04 | 371 | 156 | 10 | GO:0005938 |
| GeneOntologyCellularComponent | main axon | 5.44e-04 | 89 | 156 | 5 | GO:0044304 | |
| GeneOntologyCellularComponent | catalytic step 2 spliceosome | 8.05e-04 | 97 | 156 | 5 | GO:0071013 | |
| GeneOntologyCellularComponent | U2-type spliceosomal complex | 8.05e-04 | 97 | 156 | 5 | GO:0005684 | |
| GeneOntologyCellularComponent | plasma membrane protein complex | CORO1C GJC2 SORBS1 KCNA4 GNA14 SCN1A SCN2A GNB5 SCN5A SCN8A SCN9A KCNS2 CTNNA1 C9 GNB3 | 8.08e-04 | 785 | 156 | 15 | GO:0098797 |
| GeneOntologyCellularComponent | U5 snRNP | 8.31e-04 | 25 | 156 | 3 | GO:0005682 | |
| GeneOntologyCellularComponent | myosin complex | 9.87e-04 | 59 | 156 | 4 | GO:0016459 | |
| GeneOntologyCellularComponent | U2 snRNP | 1.16e-03 | 28 | 156 | 3 | GO:0005686 | |
| GeneOntologyCellularComponent | methyltransferase complex | 1.30e-03 | 108 | 156 | 5 | GO:0034708 | |
| GeneOntologyCellularComponent | acetyltransferase complex | 1.36e-03 | 109 | 156 | 5 | GO:1902493 | |
| GeneOntologyCellularComponent | synaptic membrane | ACHE SHC4 LRRTM3 CLSTN1 OPRD1 KCNA4 SCN1A SCN2A GNB5 SCN8A LRP4 PPP1R9B | 1.46e-03 | 583 | 156 | 12 | GO:0097060 |
| GeneOntologyCellularComponent | zonula adherens | 1.50e-03 | 8 | 156 | 2 | GO:0005915 | |
| GeneOntologyCellularComponent | cell-cell junction | EPPK1 GJC2 SORBS1 KEAP1 B4GALT1 PCDHGA12 SCN1A SCN2A PVR SCN5A PPP1R9B CTNNA1 | 1.63e-03 | 591 | 156 | 12 | GO:0005911 |
| GeneOntologyCellularComponent | intercalated disc | 1.68e-03 | 68 | 156 | 4 | GO:0014704 | |
| GeneOntologyCellularComponent | cytoplasmic side of membrane | 1.74e-03 | 230 | 156 | 7 | GO:0098562 | |
| GeneOntologyCellularComponent | spine apparatus | 1.92e-03 | 9 | 156 | 2 | GO:0097444 | |
| GeneOntologyCellularComponent | cation channel complex | 1.96e-03 | 235 | 156 | 7 | GO:0034703 | |
| GeneOntologyCellularComponent | heterotrimeric G-protein complex | 2.24e-03 | 35 | 156 | 3 | GO:0005834 | |
| HumanPheno | Infantile muscular hypotonia | FAT4 GAMT B4GALT1 KMT2D TELO2 ARID2 SCN1A PGAP2 SCN2A SCN9A SNRPN | 2.32e-05 | 219 | 57 | 11 | HP:0008947 |
| HumanPheno | Complex febrile seizure | 2.32e-05 | 16 | 57 | 4 | HP:0011172 | |
| HumanPheno | Intellectual disability, severe | FAT4 AMT GAMT EEF1A2 TELO2 ARID2 SCN1A PGAP2 SCN2A GNB5 SCN8A ASPM HSD17B10 SNRPN | 3.95e-05 | 371 | 57 | 14 | HP:0010864 |
| HumanPheno | Photosensitive myoclonic seizure | 7.15e-05 | 8 | 57 | 3 | HP:0001327 | |
| HumanPheno | Cyanotic episode | 7.15e-05 | 8 | 57 | 3 | HP:0200048 | |
| Domain | Na_trans_cytopl | 2.13e-10 | 6 | 154 | 5 | PF11933 | |
| Domain | Na_trans_cytopl | 2.13e-10 | 6 | 154 | 5 | IPR024583 | |
| Domain | IQ | 1.23e-09 | 81 | 154 | 10 | SM00015 | |
| Domain | IQ_motif_EF-hand-BS | 3.52e-09 | 90 | 154 | 10 | IPR000048 | |
| Domain | IQ | 4.87e-09 | 93 | 154 | 10 | PS50096 | |
| Domain | Na_channel_asu | 8.70e-09 | 10 | 154 | 5 | IPR001696 | |
| Domain | Na_trans_assoc | 8.70e-09 | 10 | 154 | 5 | IPR010526 | |
| Domain | Na_trans_assoc | 8.70e-09 | 10 | 154 | 5 | PF06512 | |
| Domain | IQ | 1.22e-07 | 71 | 154 | 8 | PF00612 | |
| Domain | Channel_four-helix_dom | 4.23e-07 | 57 | 154 | 7 | IPR027359 | |
| Domain | - | 4.23e-07 | 57 | 154 | 7 | 1.20.120.350 | |
| Domain | Ion_trans_dom | 4.45e-05 | 114 | 154 | 7 | IPR005821 | |
| Domain | Ion_trans | 4.45e-05 | 114 | 154 | 7 | PF00520 | |
| Domain | snRNP-assoc_SmB/SmN | 6.75e-05 | 2 | 154 | 2 | IPR017131 | |
| Domain | Transl_elong_EF1A_euk/arc | 6.75e-05 | 2 | 154 | 2 | IPR004539 | |
| Domain | P-loop_NTPase | ABCC4 ABCA3 MYO5B MYO7A MYO7B MYO9B CARD10 CHD1 CMSS1 EEF1A1 EEF1A2 RAB36 GNA14 RUVBL1 ASPM DDX39A SNRNP200 AQR | 2.22e-04 | 848 | 154 | 18 | IPR027417 |
| Domain | Myosin_head_motor_dom | 2.64e-04 | 38 | 154 | 4 | IPR001609 | |
| Domain | MYOSIN_MOTOR | 2.64e-04 | 38 | 154 | 4 | PS51456 | |
| Domain | Myosin_head | 2.64e-04 | 38 | 154 | 4 | PF00063 | |
| Domain | MYSc | 2.64e-04 | 38 | 154 | 4 | SM00242 | |
| Domain | ARM-like | 4.12e-04 | 270 | 154 | 9 | IPR011989 | |
| Domain | - | 5.19e-04 | 222 | 154 | 8 | 1.25.10.10 | |
| Domain | Guanine_nucleotide-bd_bsu | 6.65e-04 | 5 | 154 | 2 | IPR016346 | |
| Pathway | REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS | 6.34e-06 | 31 | 122 | 5 | M877 | |
| Pathway | REACTOME_PHASE_0_RAPID_DEPOLARISATION | 7.47e-06 | 32 | 122 | 5 | M27455 | |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | EPPK1 APMAP CORO1C DNAJA2 PSMB4 COX7C ISOC1 EEF1A1 EPG5 EEF1A2 TXNRD1 ACTR1A SF3B3 RUVBL1 PRDX3 SCN8A DAAM2 HSD17B10 EIF3A CTNNA1 PRDX5 PC DDX39A SNRNP200 SNRPN | 4.86e-14 | 807 | 159 | 25 | 30575818 |
| Pubmed | 2.33e-10 | 9 | 159 | 5 | 16382098 | ||
| Pubmed | 2.34e-09 | 13 | 159 | 5 | 15123669 | ||
| Pubmed | Histone methyltransferase DOT1L coordinates AR and MYC stability in prostate cancer. | EPPK1 MYO5B PSMB4 TXNRD1 KMT2D UBR5 TELO2 MMS19 CTNNA1 SNRNP200 BAG6 SEC23B | 3.78e-09 | 264 | 159 | 12 | 32814769 |
| Pubmed | FLT4 DNAJA2 PSMB4 PAM16 CMSS1 TXNRD1 ACTR1A KAT2B PTPN14 SF3B3 RUVBL1 UBR5 ASPM HSD17B10 EIF3A ALDH3A2 SNRPB SNRNP200 BAG6 AQR RPL13 | 4.10e-09 | 971 | 159 | 21 | 33306668 | |
| Pubmed | A 'toothache tree' alkylamide inhibits Aδ mechanonociceptors to alleviate mechanical pain. | 6.26e-09 | 6 | 159 | 4 | 23652591 | |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | EPPK1 DNAJA2 ISOC1 CHD1 PAM16 CMSS1 EEF1A1 EEF1A1P5 TXNRD1 SF3B3 RUVBL1 UBR5 PRDX3 HSD17B10 EIF3A CTNNA1 PRDX5 PC SNRPB SNRNP200 BAG6 SNRPN SEC23B AQR RPL13 | 7.08e-09 | 1415 | 159 | 25 | 28515276 |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | EPPK1 MYO5B MYO9B APMAP CORO1C CHD1 URB2 EEF1A1 SCAF1 SF3B3 RUVBL1 UBR5 PRDX3 HSD17B10 EIF3A CTNNA1 SNRPB SNRNP200 BAG6 AQR RPL13 | 1.03e-08 | 1024 | 159 | 21 | 24711643 |
| Pubmed | CORO1C TSPYL2 MUS81 CHD1 PAM16 ACTR1A SF3B3 RUVBL1 ARID2 PRDX3 EIF3A ALDH3A2 DDX39A NFAT5 SNRNP200 SNRPN CDCA7L AQR RPL13 | 1.34e-08 | 847 | 159 | 19 | 35850772 | |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | APMAP DUSP1 DNAJA2 PSMB4 KEAP1 EEF1A1 EEF1A1P5 EEF1A2 ACTR1A SF3B3 RUVBL1 UBR5 TELO2 MMS19 HSD17B10 ALDH3A2 SNRPB DDX39A SNRNP200 BAG6 SNRPN SEC23B RPL13 | 1.60e-08 | 1257 | 159 | 23 | 37317656 |
| Pubmed | RALGAPB GJC2 CHD1 KEAP1 TIPRL SCAF1 SCAP SF3B3 UBR5 CENPM DBX1 ARID2 PGAP2 GNB5 ASPM HSD17B10 ATP13A3 PRDX5 ALDH3A2 PC RUNDC1 BAG6 RPL13 | 4.30e-08 | 1327 | 159 | 23 | 32694731 | |
| Pubmed | 5.21e-08 | 9 | 159 | 4 | 15746173 | ||
| Pubmed | 9.38e-08 | 3 | 159 | 3 | 32845893 | ||
| Pubmed | 9.38e-08 | 3 | 159 | 3 | 28518218 | ||
| Pubmed | 9.38e-08 | 3 | 159 | 3 | 17928448 | ||
| Pubmed | USP45 and Spindly are part of the same complex implicated in cell migration. | EPPK1 CLSTN1 EEF1A1P5 EEF1A2 SF3B3 UBR5 EIF3A SNRNP200 BAG6 RPL13 | 1.45e-07 | 235 | 159 | 10 | 30258100 |
| Pubmed | CHD1 SCAF1 SF3B3 RUVBL1 TELO2 ALDH3A2 SNRPB SNRNP200 SNRPN AQR RPL13 | 1.53e-07 | 300 | 159 | 11 | 28561026 | |
| Pubmed | MYO5B MYO7A CORO1C DNAJA2 GJC2 SORBS1 WDR37 EEF1A1 EEF1A2 ACTR1A SF3B3 SCN2A GNB5 PPP1R9B EIF3A CTNNA1 GNB3 PRDX5 CROCC PC SNRNP200 SNRPN RPL13 | 1.66e-07 | 1431 | 159 | 23 | 37142655 | |
| Pubmed | Nav1.2 haplodeficiency in excitatory neurons causes absence-like seizures in mice. | 2.02e-07 | 12 | 159 | 4 | 30175250 | |
| Pubmed | PDHA2 CORO1C DNAJA2 PSMB4 ISOC1 TIPRL EEF1A1 ACTR1A SF3B3 RUVBL1 UBR5 PRDX3 MMS19 HSD17B10 EIF3A CTNNA1 ALDH3A2 PC SNRPB SNRNP200 SEC23B RPL13 | 2.07e-07 | 1335 | 159 | 22 | 29229926 | |
| Pubmed | DNAJA2 TSPYL2 KEAP1 WDR37 SCAF1 KSR1 KAT2B PTPN14 SF3B3 RASAL3 SLC35F3 UBR5 TELO2 ARID2 SCN5A ASPM LRP4 MCRS1 MMS19 PADI2 | 2.10e-07 | 1116 | 159 | 20 | 31753913 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | L3MBTL2 MYO9B CORO1C DNAJA2 PSMB4 ISOC1 CHD1 URB2 CMSS1 ACTR1A PTPN14 SF3B3 RUVBL1 UBR5 ASPM MMS19 EIF3A DDX39A SNRNP200 BAG6 AQR RPL13 | 2.60e-07 | 1353 | 159 | 22 | 29467282 |
| Pubmed | L3MBTL2 CORO1C DNAJA2 FRYL KEAP1 EEF1A1 SF3B3 RUVBL1 HSD17B10 EIF3A SNRPB SNRNP200 AQR RPL13 | 2.74e-07 | 551 | 159 | 14 | 34728620 | |
| Pubmed | 3.74e-07 | 4 | 159 | 3 | 17537961 | ||
| Pubmed | 3.74e-07 | 4 | 159 | 3 | 35031483 | ||
| Pubmed | 3.74e-07 | 4 | 159 | 3 | 29578003 | ||
| Pubmed | 3.74e-07 | 4 | 159 | 3 | 21156207 | ||
| Pubmed | 4.06e-07 | 14 | 159 | 4 | 8022818 | ||
| Pubmed | RALGAPB HEATR5A SORBS1 URB2 FHIP2A EPG5 UBR5 DENND4B DAAM2 CROCC NFAT5 AQR | 4.26e-07 | 407 | 159 | 12 | 12693553 | |
| Pubmed | L3MBTL2 CORO1C DNAJA2 PSMB4 ACTR1A SF3B3 UBR5 TELO2 EIF3A SNRPB SNRNP200 BAG6 | 4.37e-07 | 408 | 159 | 12 | 33766124 | |
| Pubmed | The Tumor Suppressor CIC Directly Regulates MAPK Pathway Genes via Histone Deacetylation. | EPPK1 L3MBTL2 MYO5B CORO1C DNAJA2 EEF1A1 ACTR1A SF3B3 RUVBL1 EIF3A SNRPB DDX39A NFAT5 SNRNP200 | 5.38e-07 | 583 | 159 | 14 | 29844126 |
| Pubmed | Physiological and pathophysiological characteristics of ataxin-3 isoforms. | DNAJA2 PSMB4 ACTR1A SF3B3 RUVBL1 PRDX3 EIF3A PC SNRNP200 BAG6 | 7.48e-07 | 281 | 159 | 10 | 30455355 |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | CORO1C PSMB4 ISOC1 FRYL EEF1A1 EEF1A2 TXNRD1 ACTR1A RUVBL1 TELO2 PRDX3 MMS19 HSD17B10 EIF3A CTNNA1 CROCC SNRPB DDX39A SNRNP200 BAG6 SEC23B RPL13 | 8.76e-07 | 1455 | 159 | 22 | 22863883 |
| Pubmed | GRWD1 regulates ribosomal protein L23 levels via the ubiquitin-proteasome system. | 8.94e-07 | 221 | 159 | 9 | 29991511 | |
| Pubmed | 9.31e-07 | 5 | 159 | 3 | 8812438 | ||
| Pubmed | Early development of electrical excitability in the mouse enteric nervous system. | 9.31e-07 | 5 | 159 | 3 | 22875929 | |
| Pubmed | 9.31e-07 | 5 | 159 | 3 | 18649364 | ||
| Pubmed | 9.31e-07 | 5 | 159 | 3 | 17724025 | ||
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | EPPK1 MYO5B CORO1C DNAJA2 ISOC1 KEAP1 CMSS1 EEF1A1 ACTR1A PTPN14 SF3B3 RUVBL1 PPP1R9B EIF3A CTNNA1 C9 SNRPB SNRNP200 AQR RPL13 | 1.33e-06 | 1257 | 159 | 20 | 36526897 |
| Pubmed | 1.41e-06 | 120 | 159 | 7 | 27320910 | ||
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | EPPK1 CORO1C DNAJA2 PSMB4 EEF1A1 EEF1A2 ACTR1A SF3B3 RUVBL1 UBR5 PRDX3 MMS19 HSD17B10 EIF3A PRDX5 SNRPB SNRNP200 BAG6 RPL13 | 1.43e-06 | 1149 | 159 | 19 | 35446349 |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | NPR1 L3MBTL2 CORO1C DNAJA2 B4GALT1 ACTR1A SF3B3 RUVBL1 UBR5 ARID2 ASPM MCRS1 EIF3A CTNNA1 ALDH3A2 SNRPB DDX39A SNRNP200 AQR | 1.54e-06 | 1155 | 159 | 19 | 20360068 |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | EPPK1 CORO1C SHC4 CMSS1 EEF1A1 EEF1A1P5 ACTR1A SF3B3 PPP1R9B EIF3A CTNNA1 PC SNRPB DDX39A SNRNP200 SNRPN RPL13 | 1.83e-06 | 949 | 159 | 17 | 36574265 |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | MYO7A POLR2F PAM16 CMSS1 EEF1A1 EEF1A2 ACTR1A SF3B3 RUVBL1 HSD17B10 EIF3A SNRPB DDX39A SNRNP200 BAG6 RPL13 | 1.91e-06 | 847 | 159 | 16 | 35235311 |
| Pubmed | Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. | MYO5B TM9SF1 RALGAPB COX7C PAM16 URB2 KEAP1 CMSS1 TXNRD1 UBR5 TELO2 PVR EIF3A ATP13A3 BAG6 | 2.17e-06 | 754 | 159 | 15 | 33060197 |
| Pubmed | L3MBTL2 CORO1C DNAJA2 PSMB4 ACTR1A SF3B3 UBR5 TELO2 MMS19 EIF3A ALDH3A2 SNRPB SNRNP200 BAG6 | 2.19e-06 | 657 | 159 | 14 | 36180527 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | ATR APMAP CORO1C DNAJA2 CHD1 URB2 EEF1A1 ACTR1A SCAF1 SF3B3 RUVBL1 PRDX3 HSD17B10 EIF3A ALDH3A2 PC SNRPB SNRNP200 BAG6 AQR RPL13 | 2.38e-06 | 1425 | 159 | 21 | 30948266 |
| Pubmed | 2.74e-06 | 48 | 159 | 5 | 8884266 | ||
| Pubmed | Multi-omics profiling identifies a deregulated FUS-MAP1B axis in ALS/FTD-associated UBQLN2 mutants. | 3.00e-06 | 256 | 159 | 9 | 35777956 | |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | EPPK1 ATR CARD10 ACTR1A SF3B3 GNA14 RUVBL1 CTNNA1 GNB3 DDX39A SNRNP200 SEC23B AQR | 3.07e-06 | 582 | 159 | 13 | 20467437 |
| Pubmed | EEF1A1 ACTR1A SF3B3 RUVBL1 EIF3A ALDH3A2 PC DDX39A SNRNP200 RPL13 | 3.16e-06 | 330 | 159 | 10 | 32529326 | |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | CORO1C DNAJA2 CHD1 URB2 CMSS1 EEF1A1P5 EEF1A2 SCAF1 SF3B3 RUVBL1 PRDX3 HSD17B10 EIF3A PC SNRNP200 SNRPN RPL13 | 3.18e-06 | 989 | 159 | 17 | 36424410 |
| Pubmed | Diagnostic yield of genetic testing in epileptic encephalopathy in childhood. | 3.24e-06 | 7 | 159 | 3 | 25818041 | |
| Pubmed | 3.24e-06 | 7 | 159 | 3 | 15272007 | ||
| Pubmed | 3.24e-06 | 7 | 159 | 3 | 11212352 | ||
| Pubmed | Blocking an N-terminal acetylation-dependent protein interaction inhibits an E3 ligase. | PSMB4 EEF1A1 EEF1A2 TXNRD1 ACTR1A SF3B3 RUVBL1 PRDX3 HSD17B10 EIF3A SNRPB SNRNP200 | 3.26e-06 | 495 | 159 | 12 | 28581483 |
| Pubmed | NudCL2 regulates cell migration by stabilizing both myosin-9 and LIS1 with Hsp90. | EPPK1 CORO1C EEF1A1 SF3B3 HSD17B10 EIF3A PC SNRPB SNRNP200 RPL13 | 3.42e-06 | 333 | 159 | 10 | 32665550 |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | MYO9B DNAJA2 COX7C SORBS1 STAT2 PTPN14 SF3B3 UBR5 ARID2 PRDX3 ASPM HSD17B10 ALDH3A2 | 3.43e-06 | 588 | 159 | 13 | 38580884 |
| Pubmed | 3.75e-06 | 197 | 159 | 8 | 31620119 | ||
| Pubmed | Proteomic analysis and identification of cellular interactors of the giant ubiquitin ligase HERC2. | 3.76e-06 | 139 | 159 | 7 | 25476789 | |
| Pubmed | RASA1 MUS81 EEF1A1 ACTR1A SF3B3 RUVBL1 EIF3A SNRPB SNRNP200 SNRPN RPL13 | 4.57e-06 | 425 | 159 | 11 | 21081503 | |
| Pubmed | MYO5B PDHA2 MYO9B CORO1C DNAJA2 PSMB4 EEF1A1 ACTR1A PTPN14 SF3B3 RUVBL1 PRDX3 HSD17B10 CTNNA1 PRDX5 DDX39A NFAT5 AQR RPL13 | 4.67e-06 | 1247 | 159 | 19 | 27684187 | |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | EPPK1 APMAP CORO1C DNAJA2 PSMB4 FRYL KEAP1 TIPRL EEF1A1 TXNRD1 ACTR1A SF3B3 RUVBL1 HSD17B10 EIF3A CTNNA1 PC SNRPB DDX39A RPL13 | 4.71e-06 | 1367 | 159 | 20 | 32687490 |
| Pubmed | SARS-CoV-2 uses Spike glycoprotein to control the host's anaerobic metabolism by inhibiting LDHB. | EPPK1 CORO1C DNAJA2 TIPRL ACTR1A SF3B3 PRDX3 HSD17B10 EIF3A CTNNA1 GNB3 PC SNRNP200 | 4.84e-06 | 607 | 159 | 13 | 39147351 |
| Pubmed | EPPK1 DNAJA2 EEF1A1 ACTR1A KMT2D RUVBL1 EIF3A CTNNA1 C9 ALDH3A2 SNRPB SNRNP200 BAG6 RPL13 | 5.40e-06 | 711 | 159 | 14 | 33022573 | |
| Pubmed | DNAJA2 PSMB4 CHD1 EEF1A1 EEF1A1P5 EEF1A2 ACTR1A SF3B3 RUVBL1 SCN1A PRDX3 HSD17B10 EIF3A SNRPB SNRNP200 BAG6 SNRPN RPL13 | 6.08e-06 | 1153 | 159 | 18 | 29845934 | |
| Pubmed | Sodium channel Scn1b null mice exhibit prolonged QT and RR intervals. | 7.72e-06 | 9 | 159 | 3 | 17884088 | |
| Pubmed | CCT3 acts upstream of YAP and TFCP2 as a potential target and tumour biomarker in liver cancer. | 7.77e-06 | 288 | 159 | 9 | 31501420 | |
| Pubmed | DNAJA2 PSMB4 CARD10 FHIP2A ACTR1A SF3B3 UBR5 TELO2 PRDX3 LRP4 MMS19 HSD17B10 EIF3A ATP13A3 CTNNA1 PRDX5 ALDH3A2 SNRPB SNRNP200 BAG6 | 1.01e-05 | 1440 | 159 | 20 | 30833792 | |
| Pubmed | PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation. | EPPK1 ATR EEF1A1 EEF1A1P5 SF3B3 SCN5A HSD17B10 EIF3A SNRNP200 BAG6 RPL13 | 1.35e-05 | 477 | 159 | 11 | 31300519 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | RIN3 EPPK1 MYO7A MYO9B ADGRB2 MUS81 CARD10 FRYL ACTR1A SCAF1 BMP8B KMT2D SCAP SCN5A SCN8A LRP4 PC | 1.35e-05 | 1105 | 159 | 17 | 35748872 |
| Pubmed | KAT2B SF3B3 RUVBL1 UBR5 TELO2 ARID2 SNRPB SNRNP200 BAG6 SNRPN | 1.36e-05 | 390 | 159 | 10 | 17643375 | |
| Pubmed | HAPSTR1 localizes HUWE1 to the nucleus to limit stress signaling pathways. | APMAP DNAJA2 PSMB4 KEAP1 TIPRL CMSS1 UBR5 TELO2 HSD17B10 ALDH3A2 BAG6 SEC23B | 1.37e-05 | 571 | 159 | 12 | 37167062 |
| Pubmed | Proteomic analysis of SRm160-containing complexes reveals a conserved association with cohesin. | 1.41e-05 | 170 | 159 | 7 | 16159877 | |
| Pubmed | 1.51e-05 | 11 | 159 | 3 | 10644457 | ||
| Pubmed | Mouse screen reveals multiple new genes underlying mouse and human hearing loss. | L3MBTL2 AICDA MYO7A CORO1C DUSP1 RALGAPB PAM16 FRYL WDR37 MKS1 KAT2B NSMF ARID2 PGAP2 ASPM DAAM2 GNB3 RUNDC1 | 1.65e-05 | 1242 | 159 | 18 | 30973865 |
| Pubmed | A neomorphic cancer cell-specific role of MAGE-A4 in trans-lesion synthesis. | 1.79e-05 | 118 | 159 | 6 | 27377895 | |
| Pubmed | L3MBTL2 MYO7A PSMB4 ISOC1 CHD1 KEAP1 CMSS1 EEF1A2 NSMF CENPM CTNNA1 | 1.93e-05 | 496 | 159 | 11 | 31343991 | |
| Pubmed | 1.97e-05 | 35 | 159 | 4 | 24515614 | ||
| Pubmed | 2.00e-05 | 12 | 159 | 3 | 8169823 | ||
| Pubmed | Reduction of Kcnt1 is therapeutic in mouse models of SCN1A and SCN8A epilepsy. | 2.08e-05 | 2 | 159 | 2 | 37901435 | |
| Pubmed | An Scn1a epilepsy mutation in Scn8a alters seizure susceptibility and behavior. | 2.08e-05 | 2 | 159 | 2 | 26410685 | |
| Pubmed | Neuronal death and perinatal lethality in voltage-gated sodium channel alpha(II)-deficient mice. | 2.08e-05 | 2 | 159 | 2 | 10827969 | |
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 19694741 | ||
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 35348308 | ||
| Pubmed | A human homologue of Drosophila kelch associates with myosin-VIIa in specialized adhesion junctions. | 2.08e-05 | 2 | 159 | 2 | 11921171 | |
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 15760941 | ||
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 20826270 | ||
| Pubmed | Differential expression of two sodium channel subtypes in human brain. | 2.08e-05 | 2 | 159 | 2 | 1317301 | |
| Pubmed | eEF1A demonstrates paralog specific effects on HIV-1 reverse transcription efficiency. | 2.08e-05 | 2 | 159 | 2 | 30782564 | |
| Pubmed | Similar [DE]XXXL[LI] motifs differentially target GLUT8 and GLUT12 in Chinese hamster ovary cells. | 2.08e-05 | 2 | 159 | 2 | 19076329 | |
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 31439038 | ||
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 34994518 | ||
| Pubmed | Interplay Between Mitochondrial Peroxiredoxins and ROS in Cancer Development and Progression. | 2.08e-05 | 2 | 159 | 2 | 31500275 | |
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 8510173 | ||
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 31943325 | ||
| Pubmed | Severe epilepsy, retardation, and dysmorphic features with a 2q deletion including SCN1A and SCN2A. | 2.08e-05 | 2 | 159 | 2 | 15249644 | |
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 35741005 | ||
| Pubmed | Sodium channel slow inactivation interferes with open channel block. | 2.08e-05 | 2 | 159 | 2 | 27174182 | |
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 18262354 | ||
| Interaction | AGR2 interactions | EPPK1 APMAP CORO1C DNAJA2 PSMB4 COX7C ISOC1 EEF1A1 EPG5 EEF1A2 TXNRD1 ACTR1A SF3B3 RUVBL1 PRDX3 SCN8A DAAM2 HSD17B10 EIF3A CTNNA1 PRDX5 PC DDX39A SNRNP200 SNRPN | 4.33e-08 | 934 | 154 | 25 | int:AGR2 |
| Interaction | SCN4B interactions | 2.24e-07 | 8 | 154 | 4 | int:SCN4B | |
| Interaction | OBSL1 interactions | EPPK1 CORO1C DNAJA2 PSMB4 CHD1 URB2 CMSS1 EEF1A1 EEF1A2 SCAF1 SF3B3 KCNA4 RUVBL1 CENPM PRDX3 HSD17B10 EIF3A CTNNA1 SNRPB SNRNP200 AQR RPL13 | 1.45e-06 | 902 | 154 | 22 | int:OBSL1 |
| Interaction | PIH1D1 interactions | FLT4 EPPK1 POLR2F ISOC1 MKS1 EEF1A1P5 ACTR1A SF3B3 RUVBL1 UBR5 TELO2 PRDX3 HSD17B10 EIF3A SNRNP200 SNRPN CDCA7L SEC23B RPL13 | 3.25e-06 | 731 | 154 | 19 | int:PIH1D1 |
| Interaction | SCN11A interactions | 4.19e-06 | 15 | 154 | 4 | int:SCN11A | |
| Interaction | ADARB2 interactions | 7.22e-06 | 17 | 154 | 4 | int:ADARB2 | |
| Interaction | YAP1 interactions | CORO1C PSMB4 TSPYL2 CHD1 TIPRL EEF1A1 EEF1A1P5 EEF1A2 KMT2D PTPN14 SF3B3 GNA14 RUVBL1 ARID2 SCN1A PRDX3 EIF3A CTNNA1 PC SNRPB NFAT5 SNRNP200 RPL13 | 9.85e-06 | 1095 | 154 | 23 | int:YAP1 |
| Interaction | FER1L6 interactions | 1.50e-05 | 7 | 154 | 3 | int:FER1L6 | |
| Interaction | CDH5 interactions | 2.06e-05 | 109 | 154 | 7 | int:CDH5 | |
| Interaction | EAPP interactions | 2.54e-05 | 76 | 154 | 6 | int:EAPP | |
| Interaction | AAR2 interactions | EPPK1 DNAJA2 ISOC1 EEF1A1P5 SF3B3 RUVBL1 PRDX3 HSD17B10 EIF3A PRDX5 SNRPB SNRNP200 BAG6 SNRPN AQR RPL13 | 4.47e-05 | 657 | 154 | 16 | int:AAR2 |
| Interaction | DOT1L interactions | CORO1C TSPYL2 MUS81 CHD1 PAM16 SF3B3 RUVBL1 ARID2 PRDX3 EIF3A ALDH3A2 DDX39A NFAT5 SNRNP200 BAG6 SNRPN CDCA7L AQR | 4.62e-05 | 807 | 154 | 18 | int:DOT1L |
| Interaction | AR interactions | EPPK1 RASA1 MYO5B CMTM2 PSMB4 SHC4 TXNRD1 KAT2B KMT2D SF3B3 RUVBL1 UBR5 TELO2 ARID2 MCRS1 MMS19 CTNNA1 SNRNP200 BAG6 SEC23B | 7.00e-05 | 992 | 154 | 20 | int:AR |
| GeneFamily | Sodium voltage-gated channel alpha subunits | 8.56e-10 | 9 | 108 | 5 | 1203 | |
| GeneFamily | A-kinase anchoring proteins|Myosins, class VII|Deafness associated genes|FERM domain containing | 3.54e-05 | 2 | 108 | 2 | 1102 | |
| GeneFamily | Peroxiredoxins | 5.22e-04 | 6 | 108 | 2 | 953 | |
| GeneFamily | Pleckstrin homology domain containing|SH2 domain containing|C2 and RasGAP domain containing | 1.54e-03 | 10 | 108 | 2 | 830 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | ATR RASA1 MYO7A MYO9B APMAP DUSP1 MGAT4A PSMB4 RALGAPB TSPYL2 CHD1 FRYL FHIP2A EEF1A1 EPG5 KAT2B KMT2D SF3B3 RASAL3 UBR5 ARID2 DENND4B NFAT5 SNRNP200 RPL13 | 3.72e-06 | 1492 | 159 | 25 | M40023 |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.99e-07 | 174 | 157 | 8 | f1fe1f4216748a9562dd03bd48c70b23c7ff4d1d | |
| ToppCell | facs|World / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.46e-06 | 179 | 157 | 7 | 8001db3044e8657980e24422377c4fdb0d7b323e | |
| ToppCell | droplet-Heart-4Chambers-21m-Endothelial-leukocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.30e-06 | 185 | 157 | 7 | bb5a4cf93534b9bcd0923f314c389d571e91e7f8 | |
| ToppCell | Calu_3-infected-SARSCoV1|infected / Cell line, Condition and Strain | 4.78e-06 | 188 | 157 | 7 | a689d59555ecf10bf88c886197d4f7bf9be6c586 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature4_(1)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 5.49e-06 | 192 | 157 | 7 | 6bba80887d6f64cf913a5c22f62baaddda417ce0 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.28e-06 | 196 | 157 | 7 | f374cb3ec31c6eef2cef9e07547bfd1e380553af | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.28e-06 | 196 | 157 | 7 | 671c380b58d7f634b4fbec38c357d357ea4f3535 | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_airway_neuro-secretory|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.71e-06 | 198 | 157 | 7 | 2591e08e3fbee86ac40f11becd8147d6d39fded6 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.93e-06 | 199 | 157 | 7 | 19a97e27a4758e794ce7246d295e112b47931a48 | |
| ToppCell | COVID-19-kidney-PCT-S3-1|kidney / Disease (COVID-19 only), tissue and cell type | 6.93e-06 | 199 | 157 | 7 | 3e6cfc3c0b2edce0d51db9de80e38f724e6c0cb8 | |
| ToppCell | NS-critical-d_0-4-Myeloid-pDC|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.23e-05 | 144 | 157 | 6 | 0fde5cd82df9b90aefde19275cff6c2ec3c9d5cb | |
| ToppCell | PND07-Endothelial-Endothelial_lymphatic|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.31e-05 | 161 | 157 | 6 | 133b4fadb499e842c19f573f9cf09ce08c1d4813 | |
| ToppCell | PND07-Endothelial-Endothelial_lymphatic-Lymphatic_EC|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.31e-05 | 161 | 157 | 6 | 9466b8658244116f8d21f2f88fb8c2d184b1bdf2 | |
| ToppCell | PND07-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.31e-05 | 161 | 157 | 6 | cb177ca10d848d0e25399ab5ebfcde1071fb94c2 | |
| ToppCell | Tracheal-10x5prime-Stromal-Pericyte-Muscle_pericyte_pulmonary|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.46e-05 | 48 | 157 | 4 | 0b71435d798c6b25089a16b25d1d535f3c780d30 | |
| ToppCell | Mild-Myeloid-Mast|Mild / Condition, Lineage, Cell class and cell subclass | 2.66e-05 | 165 | 157 | 6 | 5fa9552c37890c5cc7e672a47038aebba2413cb4 | |
| ToppCell | Mild-Myeloid-Mast-|Mild / Condition, Lineage, Cell class and cell subclass | 2.66e-05 | 165 | 157 | 6 | 93d3909a0f5f43d473d5005c842d7d73e25eceed | |
| ToppCell | LA-12._Cytoplasmic_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 2.67e-05 | 99 | 157 | 5 | aed68765f60e54b7e2406c5f09fa744fcd844354 | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-Epcam____proximal_tube_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.24e-05 | 171 | 157 | 6 | 48fc4eca18b102b5ec5050f758281292ee8e10c6 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage-Monocyte-derived_macrophage-Monocyte-derived_macrophage_L.1.2.5.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.24e-05 | 171 | 157 | 6 | 5e93c76ee60f9d0590ebb140812653a5e1369417 | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-epithelial_cell_of_proximal_tubule|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.24e-05 | 171 | 157 | 6 | 05fcc72df50a380a913821b5781d9621df37d328 | |
| ToppCell | Adult-Epithelial-lung_neuroendocrine_cell_(PNEC)|Adult / Lineage, Cell type, age group and donor | 3.69e-05 | 175 | 157 | 6 | 4db1a3c284488b3f6de7568363f176d74e2a4587 | |
| ToppCell | Adult-Epithelial-lung_neuroendocrine_cell_(PNEC)-D231|Adult / Lineage, Cell type, age group and donor | 3.69e-05 | 175 | 157 | 6 | 8d9f44a2633b71fb4d2b4a7d9530f954e07c4a18 | |
| ToppCell | facs-Marrow-B-cells-3m-Lymphocytic-early_pro_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.81e-05 | 176 | 157 | 6 | 29cda51a99100ddd2928cadc92da40f001d7e1f4 | |
| ToppCell | facs-Marrow-B-cells-3m-Lymphocytic-early_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.81e-05 | 176 | 157 | 6 | 01774a86d7d92f31a056b753f9844f923038003e | |
| ToppCell | Control-Myeloid-Dendritic_cells|Control / group, cell type (main and fine annotations) | 4.32e-05 | 180 | 157 | 6 | 25ad95c3c30e3b82abe93bd77ba003f5c2241f7c | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c11-MKI67-FOS|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.46e-05 | 181 | 157 | 6 | 6873c1138b28c130637d06b64981ad11c262e85f | |
| ToppCell | PBMC-Mild-cDC_9|Mild / Compartment, Disease Groups and Clusters | 4.88e-05 | 184 | 157 | 6 | 2e0c9a2c40c892a2d435eafb31f1f838de9baf15 | |
| ToppCell | PCW_13-14-Endothelial-Endothelial_mature-lymphatic-endo_lymphatic_(7)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 5.03e-05 | 185 | 157 | 6 | 3be9e05b929ac4d956b1d53284072f668a6c1959 | |
| ToppCell | PCW_13-14-Endothelial-Endothelial_mature-lymphatic|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 5.03e-05 | 185 | 157 | 6 | c3dd64a726cb8a1fe048683c266b7532a714a52e | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 5.50e-05 | 188 | 157 | 6 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Neuronal-neurons_A-Branch_A1_(iMN)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.83e-05 | 190 | 157 | 6 | bdbfaced785db79ff965f332759be258dbf743cf | |
| ToppCell | wk_08-11-Endothelial-Lymph_endothelial-Lymphatic_endo|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 5.83e-05 | 190 | 157 | 6 | 279c5f68b993dc7adbf9aa69fffb1321cdebc48a | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.83e-05 | 190 | 157 | 6 | 6c7e1086c0a274cd5527c3104106e372811c9905 | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-Neutrophil-Neu_4|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 5.83e-05 | 190 | 157 | 6 | 3f0c7d130f66faea778fe567604edf1b4cdf85b3 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Alv_Gen_Intermediate|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.83e-05 | 190 | 157 | 6 | 106ea0bb7b99c697ffc5443d72343df2484250c7 | |
| ToppCell | wk_08-11-Endothelial-Lymph_endothelial|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 5.83e-05 | 190 | 157 | 6 | d7f1dc032d161529559e01832d1a3112c6f6cc1a | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_mature|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.18e-05 | 192 | 157 | 6 | 291df12b4b5ff11fbaa43033692b8f4b5cdf65a1 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_mature-Lymphatic_EC_mature_L.2.5.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.18e-05 | 192 | 157 | 6 | 35ffe7aa9ffab85eac3326651e901c39d0119650 | |
| ToppCell | Control-Myeloid-cMonocyte|Control / Disease state, Lineage and Cell class | 6.18e-05 | 192 | 157 | 6 | ad04c9c4bdebf94615cee1904ca48197e62c923b | |
| ToppCell | facs-Lung-nan-3m-Epithelial|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.18e-05 | 192 | 157 | 6 | cca2d0fedfbd946c54d6f4fc45887117c8dae58a | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-Neutrophil-Neu_4|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.18e-05 | 192 | 157 | 6 | c09dcc73ff9c3855a0f3d7bfa0d5c99c09a117f2 | |
| ToppCell | nucseq|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.36e-05 | 193 | 157 | 6 | 779276e775cb2492e8dd36436295a536084a6415 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.36e-05 | 193 | 157 | 6 | 040f6bb42aa41d0921371fdda1cc0912c4fe1930 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.36e-05 | 193 | 157 | 6 | e468287c8b30c56d1de65e8347ade233ba6cf584 | |
| ToppCell | normal_Lymph_Node-B_lymphocytes-GC_B_cells_in_the_DZ|normal_Lymph_Node / Location, Cell class and cell subclass | 6.36e-05 | 193 | 157 | 6 | 5ce93860bc60ce6ecfed3a3d985f84e28781eec1 | |
| ToppCell | PCW_13-14-Endothelial-Endothelial_immature-endo_immature4_(5)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 6.36e-05 | 193 | 157 | 6 | 01c71aa48875b5ad6c50cc810a72862e72f26ad0 | |
| ToppCell | Control-Myeloid-cMonocyte|World / Disease state, Lineage and Cell class | 6.55e-05 | 194 | 157 | 6 | f852f5258617a66a4fbd56d64c7b47272e7b8b60 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Neuronal-neurons_B|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.55e-05 | 194 | 157 | 6 | 15224fb3e7ca5bd1fb8c41f8275842f737014095 | |
| ToppCell | COVID-19-kidney-Glomerular_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.55e-05 | 194 | 157 | 6 | 660535b492445063d965095a50e1e299ce04c50a | |
| ToppCell | PCW_10-12-Endothelial-Endothelial_immature-endo_immature4_(5)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 6.55e-05 | 194 | 157 | 6 | 53a5e8863d79a052dff0758f389be5ac3883c721 | |
| ToppCell | mild_COVID-19|World / disease group, cell group and cell class (v2) | 6.74e-05 | 195 | 157 | 6 | 6dbe9db5f0e94f2e91b3d1282855d200051ab0ba | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)|renal_medulla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 6.74e-05 | 195 | 157 | 6 | 633c7668fe365f7b0f7851cdc442d5dd89c454e2 | |
| ToppCell | (3)_MNP-(3)_Monocyte|(3)_MNP / Lung cell shreds - cell class (v4) and cell subclass (v4) | 6.93e-05 | 196 | 157 | 6 | 83af2eb1c28dfe7678d972be1d6d358c4a94731d | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_airway_neuro-secretory-Neuroendocrine|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 7.13e-05 | 197 | 157 | 6 | 3a0e97bfebe82f9687d518baaad7f20d0ffea8a1 | |
| ToppCell | (5)_Dendritic_cell-(54)_pDC|(5)_Dendritic_cell / shred on Cell_type and subtype | 7.33e-05 | 198 | 157 | 6 | fc6c6b60dddd7f2f997af0f87fae33f1c23f34a8 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_neuro-secretory-Neuroendocrine|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.33e-05 | 198 | 157 | 6 | 8f25e8dff42bad8e779ca618bdb1cb1610667962 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Neuronal-neurons_A|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.33e-05 | 198 | 157 | 6 | 50504a3871f76d6a5b439a56450d7770f4501eb0 | |
| ToppCell | Control|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 7.33e-05 | 198 | 157 | 6 | 73694b6109c1f6878b6b5997e434bbc3cec1dc70 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_neuro-secretory|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.33e-05 | 198 | 157 | 6 | e3e0aa3ef20b2370f5b133048510677aaa562dfa | |
| ToppCell | COVID-19-Heart-Mito_EC|Heart / Disease (COVID-19 only), tissue and cell type | 7.33e-05 | 198 | 157 | 6 | 3cc34b5d333abba11ab846c26fb4477051958465 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA-|Macroglial / cells hierarchy compared to all cells using T-Statistic | 7.75e-05 | 200 | 157 | 6 | f17b5a54e8f9eba9dcd0808ba4e8d275ac41bce2 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA--|Macroglial / cells hierarchy compared to all cells using T-Statistic | 7.75e-05 | 200 | 157 | 6 | cc3409518f8b436ea92deb955e81114b3f410ff7 | |
| ToppCell | Sepsis-Leuk-UTI-Lymphocyte-T/NK-CD4+_T_naive|Leuk-UTI / Disease, condition lineage and cell class | 7.75e-05 | 200 | 157 | 6 | a542c302ac266ed0ead355b5011f0aff39320ed7 | |
| ToppCell | Calu_3-uninfected|Calu_3 / Cell line, Condition and Strain | 7.75e-05 | 200 | 157 | 6 | cb9b6a6b085ae0e19b450940c4ecd92406d8a2b3 | |
| ToppCell | MS-IIF-Lymphocyte-T/NK-CD8+_Tcm|IIF / Disease, condition lineage and cell class | 7.75e-05 | 200 | 157 | 6 | 01554c0b7b8d7a12d99853fe057a20ed775ee5b2 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA|Macroglial / cells hierarchy compared to all cells using T-Statistic | 7.75e-05 | 200 | 157 | 6 | c24a3099e3d96d8b72f6d05286bb355d661a0377 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA---|Macroglial / cells hierarchy compared to all cells using T-Statistic | 7.75e-05 | 200 | 157 | 6 | 4fc3de4bff7ed2bf40b38462c4b4e9b87af6a4ca | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA----L1-6|Macroglial / cells hierarchy compared to all cells using T-Statistic | 7.75e-05 | 200 | 157 | 6 | 310cd53db1c137f6af74e6ae682221d7ac27310c | |
| ToppCell | Macroglial-Polydendrocytes|Macroglial / cells hierarchy compared to all cells using T-Statistic | 7.75e-05 | 200 | 157 | 6 | 961858738ce35db8760c8c2e136f8369bc444ccf | |
| ToppCell | PBMC-Control-Lymphocyte-B-B_cell-B_intermediate-B_activate-7|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.44e-05 | 126 | 157 | 5 | 518a6e4919981b556ce6b451a91270dba976bc75 | |
| Drug | APETx2 protein, Anthopleura elegantissima | 1.28e-06 | 4 | 157 | 3 | ctd:C501880 | |
| Drug | Zonisamide | 4.83e-06 | 17 | 157 | 4 | DB00909 | |
| Disease | generalized epilepsy with febrile seizures plus 2 (implicated_via_orthology) | 8.95e-10 | 10 | 154 | 5 | DOID:0111294 (implicated_via_orthology) | |
| Disease | Dravet syndrome (implicated_via_orthology) | 8.95e-10 | 10 | 154 | 5 | DOID:0080422 (implicated_via_orthology) | |
| Disease | generalized epilepsy with febrile seizures plus (implicated_via_orthology) | 2.79e-09 | 12 | 154 | 5 | DOID:0060170 (implicated_via_orthology) | |
| Disease | developmental and epileptic encephalopathy 33 (implicated_via_orthology) | 1.39e-07 | 3 | 154 | 3 | DOID:0080463 (implicated_via_orthology) | |
| Disease | epilepsy (implicated_via_orthology) | 2.05e-07 | 163 | 154 | 9 | DOID:1826 (implicated_via_orthology) | |
| Disease | Epilepsy | 1.76e-06 | 109 | 154 | 7 | C0014544 | |
| Disease | Epilepsy, Cryptogenic | 4.63e-06 | 82 | 154 | 6 | C0086237 | |
| Disease | Awakening Epilepsy | 4.63e-06 | 82 | 154 | 6 | C0751111 | |
| Disease | Aura | 4.63e-06 | 82 | 154 | 6 | C0236018 | |
| Disease | Generalized Epilepsy with Febrile Seizures Plus | 1.14e-05 | 9 | 154 | 3 | C3502809 | |
| Disease | Early Infantile Epileptic Encephalopathy 6 | 2.71e-05 | 2 | 154 | 2 | C4551549 | |
| Disease | Infantile Severe Myoclonic Epilepsy | 3.84e-05 | 13 | 154 | 3 | C0751122 | |
| Disease | B Virus Infection | 8.09e-05 | 3 | 154 | 2 | C0037140 | |
| Disease | Benign familial infantile epilepsy | 8.09e-05 | 3 | 154 | 2 | cv:C5575231 | |
| Disease | Postherpetic neuralgia | 8.09e-05 | 3 | 154 | 2 | C0032768 | |
| Disease | Herpesviridae Infections | 8.09e-05 | 3 | 154 | 2 | C0019372 | |
| Disease | Stomach Neoplasms | 1.76e-04 | 297 | 154 | 8 | C0038356 | |
| Disease | Malignant neoplasm of stomach | 1.88e-04 | 300 | 154 | 8 | C0024623 | |
| Disease | anxiety disorder (implicated_via_orthology) | 2.00e-04 | 22 | 154 | 3 | DOID:2030 (implicated_via_orthology) | |
| Disease | Milroy Disease | 2.68e-04 | 5 | 154 | 2 | C1704423 | |
| Disease | mean platelet volume | RIN3 PCDHGB7 COL6A6 MYO9B CORO1C POLR2F FRYL SORBS1 OPRD1 EEF1A1P5 PCDHGA12 PVR ATP13A3 ALDH3A2 TRIM48 | 3.05e-04 | 1020 | 154 | 15 | EFO_0004584 |
| Disease | Drug habituation | 3.51e-04 | 115 | 154 | 5 | C0013170 | |
| Disease | Drug abuse | 3.51e-04 | 115 | 154 | 5 | C0013146 | |
| Disease | Prescription Drug Abuse | 3.51e-04 | 115 | 154 | 5 | C4316881 | |
| Disease | Substance-Related Disorders | 3.51e-04 | 115 | 154 | 5 | C0236969 | |
| Disease | Drug Use Disorders | 3.51e-04 | 115 | 154 | 5 | C0013222 | |
| Disease | Drug Dependence | 3.51e-04 | 115 | 154 | 5 | C1510472 | |
| Disease | Substance Dependence | 3.51e-04 | 115 | 154 | 5 | C0038580 | |
| Disease | Substance Use Disorders | 3.51e-04 | 115 | 154 | 5 | C0038586 | |
| Disease | Organic Mental Disorders, Substance-Induced | 3.51e-04 | 115 | 154 | 5 | C0029231 | |
| Disease | Substance abuse problem | 3.65e-04 | 116 | 154 | 5 | C0740858 | |
| Disease | Familial benign neonatal epilepsy | 4.00e-04 | 6 | 154 | 2 | C0220669 | |
| Disease | Seizure, Febrile, Simple | 5.59e-04 | 7 | 154 | 2 | C0149886 | |
| Disease | Seizure, Febrile, Complex | 5.59e-04 | 7 | 154 | 2 | C0751057 | |
| Disease | Early Childhood Epilepsy, Myoclonic | 7.42e-04 | 8 | 154 | 2 | C0393695 | |
| Disease | Idiopathic Myoclonic Epilepsy | 7.42e-04 | 8 | 154 | 2 | C0338478 | |
| Disease | Symptomatic Myoclonic Epilepsy | 7.42e-04 | 8 | 154 | 2 | C0338479 | |
| Disease | Benign Infantile Myoclonic Epilepsy | 7.42e-04 | 8 | 154 | 2 | C0751120 | |
| Disease | Myoclonic Encephalopathy | 7.42e-04 | 8 | 154 | 2 | C0438414 | |
| Disease | Myoclonic Absence Epilepsy | 7.42e-04 | 8 | 154 | 2 | C0393703 | |
| Disease | Hereditary Diffuse Gastric Cancer | 9.09e-04 | 293 | 154 | 7 | C1708349 | |
| Disease | Tremor, Neonatal | 9.51e-04 | 9 | 154 | 2 | C0235843 | |
| Disease | Febrile Convulsions | 9.51e-04 | 9 | 154 | 2 | C0009952 | |
| Disease | Tremor, Perioral | 9.51e-04 | 9 | 154 | 2 | C0235078 | |
| Disease | Nerve Tremors | 9.51e-04 | 9 | 154 | 2 | C0235083 | |
| Disease | Tremor, Limb | 9.51e-04 | 9 | 154 | 2 | C0235081 | |
| Disease | Tremor, Muscle | 9.51e-04 | 9 | 154 | 2 | C0235082 | |
| Disease | Senile Tremor | 9.51e-04 | 9 | 154 | 2 | C0149840 | |
| Disease | Pill Rolling Tremor | 9.51e-04 | 9 | 154 | 2 | C0751564 | |
| Disease | Tremor, Semirhythmic | 9.51e-04 | 9 | 154 | 2 | C0751565 | |
| Disease | Action Tremor | 9.51e-04 | 9 | 154 | 2 | C0234376 | |
| Disease | Passive Tremor | 9.51e-04 | 9 | 154 | 2 | C0234377 | |
| Disease | Static Tremor | 9.51e-04 | 9 | 154 | 2 | C0234378 | |
| Disease | Resting Tremor | 9.51e-04 | 9 | 154 | 2 | C0234379 | |
| Disease | Intermittent Tremor | 9.51e-04 | 9 | 154 | 2 | C0234372 | |
| Disease | Fine Tremor | 9.51e-04 | 9 | 154 | 2 | C0234373 | |
| Disease | Coarse Tremor | 9.51e-04 | 9 | 154 | 2 | C0234374 | |
| Disease | Massive Tremor | 9.51e-04 | 9 | 154 | 2 | C0234375 | |
| Disease | Persistent Tremor | 9.51e-04 | 9 | 154 | 2 | C0234370 | |
| Disease | Continuous Tremor | 9.51e-04 | 9 | 154 | 2 | C0234371 | |
| Disease | Darkness Tremor | 9.51e-04 | 9 | 154 | 2 | C0234381 | |
| Disease | Involuntary Quiver | 9.51e-04 | 9 | 154 | 2 | C1527384 | |
| Disease | Saturnine Tremor | 9.51e-04 | 9 | 154 | 2 | C0040827 | |
| Disease | Myoclonic Epilepsy | 9.51e-04 | 9 | 154 | 2 | C0014550 | |
| Disease | thoracic aortic calcification measurement | 9.51e-04 | 9 | 154 | 2 | EFO_0010273 | |
| Disease | tauopathy (implicated_via_orthology) | 1.18e-03 | 10 | 154 | 2 | DOID:680 (implicated_via_orthology) | |
| Disease | Epilepsy, Myoclonic, Infantile | 1.18e-03 | 10 | 154 | 2 | C0917800 | |
| Disease | gastric adenocarcinoma (is_implicated_in) | 1.44e-03 | 11 | 154 | 2 | DOID:3717 (is_implicated_in) | |
| Disease | Sepsis, mortality | 1.44e-03 | 11 | 154 | 2 | EFO_0004352, HP_0100806 | |
| Disease | Tremor | 1.44e-03 | 11 | 154 | 2 | C0040822 | |
| Disease | Myoclonic Astatic Epilepsy | 1.44e-03 | 11 | 154 | 2 | C0393702 | |
| Disease | Neurodevelopmental Disorders | 1.45e-03 | 93 | 154 | 4 | C1535926 | |
| Disease | Prostatic Neoplasms | 1.53e-03 | 616 | 154 | 10 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 1.53e-03 | 616 | 154 | 10 | C0376358 | |
| Disease | age-related hearing impairment | 1.62e-03 | 324 | 154 | 7 | EFO_0005782 | |
| Disease | MMR-related febrile seizures | 2.72e-03 | 15 | 154 | 2 | EFO_0006519 | |
| Disease | vitamin K-dependent protein C measurement | 2.72e-03 | 15 | 154 | 2 | EFO_0008318 | |
| Disease | Early infantile epileptic encephalopathy with suppression bursts | 3.10e-03 | 16 | 154 | 2 | C0393706 | |
| Disease | macula measurement | 3.20e-03 | 189 | 154 | 5 | EFO_0008375 | |
| Disease | Benign neoplasm of stomach | 3.50e-03 | 17 | 154 | 2 | C0153943 | |
| Disease | Neoplasm of uncertain or unknown behavior of stomach | 3.50e-03 | 17 | 154 | 2 | C0496905 | |
| Disease | Antibody Deficiency Syndrome | 3.50e-03 | 17 | 154 | 2 | C0003257 | |
| Disease | Carcinoma in situ of stomach | 3.50e-03 | 17 | 154 | 2 | C0154060 | |
| Disease | Febrile seizure (within the age range of 3 months to 6 years) | 3.92e-03 | 18 | 154 | 2 | HP_0002373 | |
| Disease | neuroimaging measurement, brain volume measurement | 4.00e-03 | 286 | 154 | 6 | EFO_0004346, EFO_0006930 | |
| Disease | pulmonary non-tuberculous mycobacterial infection | 4.37e-03 | 19 | 154 | 2 | MONDO_0018469 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RDIRSQIEAMFRGGI | 231 | Q14146 | |
| GRFLVQAERTVLVSM | 166 | P22303 | |
| SYLAVIGRMRTRLVR | 1021 | O60241 | |
| RFRVVARSMAAFLSV | 2481 | Q9HCE0 | |
| DIFNRLVFRGMSISR | 316 | P15291 | |
| GLTQFLMTEVRRLRE | 131 | Q9BWT7 | |
| MLGQSIRRFTTSVVR | 1 | P15954 | |
| VLRADIFSRMRTLVA | 186 | Q96HD9 | |
| LAAVINGRIRRMSRG | 891 | P46379 | |
| TGRAFMIIQEQRTRA | 601 | Q9H5V8 | |
| ALQRMSVVARVLGDR | 631 | Q9H7F0 | |
| QRRILVATNLFGRGM | 336 | O00148 | |
| LMRRRGTAVFSFTVI | 1166 | Q6V0I7 | |
| LRRLHRAGVQIAIMT | 126 | Q9GZX7 | |
| FITSRVAVEGNVRRM | 686 | Q5VV41 | |
| LMALRRGSRNLVFRD | 1741 | Q68CP9 | |
| VRALELIRSMTAFRG | 166 | Q9BQ75 | |
| MRRVVRQSKFRHVFG | 1 | Q9ULV4 | |
| TVRRALVINMRVRGF | 96 | Q99758 | |
| MELEVRRVRQAFLSG | 1 | P51648 | |
| LQGVRFLSSREVDRM | 36 | Q96CM8 | |
| DVRRLVVAMSRARLG | 1286 | O60306 | |
| GRVFRVTFLMLAVSL | 36 | Q9HDC9 | |
| KIVRRNATMIFGILA | 81 | Q5W041 | |
| LVFMIILGVFRIRAA | 871 | O94985 | |
| ILGVFRIRAAHRRTM | 876 | O94985 | |
| EGLFMRVRDRLNITV | 201 | P16066 | |
| RERGNRVLIFSQMVR | 801 | O14646 | |
| MVAPAARVFLRAVRA | 1 | Q86SI9 | |
| SVRTIQAAFRGMKVR | 2741 | Q8IZT6 | |
| ELAAAMVRVLRATGR | 461 | Q86YV0 | |
| MVRVLRATGRAQALV | 466 | Q86YV0 | |
| TIRVARRSRVALVAM | 26 | O95755 | |
| RRSRVALVAMVIAAA | 31 | O95755 | |
| MRTRVVSGFVFLRLI | 891 | P20936 | |
| RRARSFVMAVSVDGR | 301 | Q9NS39 | |
| RVEALGQFVMKTRRT | 86 | O14775 | |
| VRTGTARIRVMVLDA | 221 | O60330 | |
| GSLARFRNISRIMRV | 76 | P28070 | |
| RTRIMIGLTLVFFVQ | 276 | Q8TD20 | |
| LFSLGLRTGEVRMVR | 616 | Q9Y5F8 | |
| RSRARRMLAGSVVIV | 491 | Q6IWH7 | |
| IIFAILRMSSAEGRR | 221 | P0C7N1 | |
| ALRTQPMRFVTRFIE | 136 | Q86T65 | |
| MRLRNGTVATALAFI | 1 | Q9UM21 | |
| DGTLVRLRFTMVALV | 11 | Q9UHJ9 | |
| MFALERLARTGIIVT | 246 | Q96CN7 | |
| SMVTRAHVRRVLGAV | 171 | Q9HB89 | |
| ATMVVRNRRLTVTRG | 856 | P19827 | |
| VFGRTLLRSVFTVMR | 306 | Q92831 | |
| RMAVVDTVIGGRLRL | 341 | Q969R5 | |
| REGLMRVYVAQLVAR | 206 | Q5T442 | |
| VLTRAGHAEVRIMFR | 851 | Q96T76 | |
| LLRMVRQGRREEAGT | 61 | Q8NAA5 | |
| ISVRGLAQAQRLIRM | 106 | Q96I76 | |
| QMVRRDIGLSVTHRF | 336 | Q8IVT5 | |
| GMLRRAVFSDVQRKA | 181 | A6NMT0 | |
| RMNIGLRVFLVIADS | 446 | O94915 | |
| GRVAQVLRLMRIFRI | 291 | Q9ULS6 | |
| LRMVGSRRVKAQTFA | 266 | Q6X4W1 | |
| GLEVVGRVQMRTRRT | 36 | P16520 | |
| VRRAFSEGQITRRMN | 256 | Q96GN5 | |
| MVRIPSRAAARFLAR | 381 | Q9UHC3 | |
| IRKRVVRVFQSGQGM | 301 | Q8NH57 | |
| MLRERTVRLQYGSRV | 1 | Q9Y2J8 | |
| ARLVFRVNIMRKDGS | 411 | O94916 | |
| RVLDVNLMGTFNVIR | 116 | Q99714 | |
| LRRITRMVLVVVGAF | 256 | P41143 | |
| RAAIFVVARNGLLTM | 146 | P0C7T3 | |
| ARIRTMNEVITGIRI | 271 | O15439 | |
| SIFGNRRLKRFSMVV | 171 | P30044 | |
| RRLKRFSMVVQDGIV | 176 | P30044 | |
| ACRGRGVRIMIRQLA | 161 | O60884 | |
| FFLLRNIRTKMGRVS | 411 | O43826 | |
| MVLTRIIAIVFFRRQ | 211 | Q13535 | |
| RQVVGFRRLVSEVKM | 301 | Q5TZA2 | |
| GLEMLLVVIRRFATV | 1286 | Q86XA9 | |
| RGNMVRAARALLSAV | 121 | P35221 | |
| VRFSTIVRRRAKGAM | 46 | P28562 | |
| TRIGLINDMVRFNVL | 366 | Q14152 | |
| LGRFAVRDMRQTVAV | 421 | Q05639 | |
| LGRFAVRDMRQTVAV | 421 | P68104 | |
| EGFRATMAQRLVRVL | 136 | Q9NSP4 | |
| MRIDIAGRDVSRFLR | 181 | P61163 | |
| FDNQTLAVLRGRMVR | 341 | Q96EZ8 | |
| GFRRENIRTEVMALV | 201 | Q14353 | |
| RLEREVQGAFLRFMA | 561 | O75064 | |
| LGRFAVRDMRQTVAV | 421 | Q5VTE0 | |
| MLTRRIGVGVAVLNR | 456 | Q14145 | |
| FSVIVRVVGDLMLRI | 691 | Q5W0V3 | |
| MQRAVSVVARLGFRL | 1 | P48728 | |
| MGIFQLLRDRRISSR | 1 | Q08E93 | |
| ERRLGRADLVMSFVN | 96 | P34820 | |
| LFGLEIRMRRIVFAG | 16 | Q5W0N0 | |
| IRMRRIVFAGVILFR | 21 | Q5W0N0 | |
| ARTRLAQRLIMAGTV | 511 | Q12770 | |
| NMAAVGRLQAVSRRL | 131 | Q9C0B2 | |
| SLRMARANARLFGIR | 181 | P26373 | |
| EIGRAMRFISRNVFK | 1841 | A6NMZ7 | |
| IHLGRFVMRNRDVVL | 301 | P02748 | |
| ILHRVVAGMFLVRRD | 76 | Q8TB24 | |
| RVVFVGNFLRINMVS | 541 | Q8TE04 | |
| MLAAFISRVLRRVAQ | 1 | P29803 | |
| IFRMVDVGGQRSERR | 196 | O95837 | |
| AELRNASLRMFGLRV | 101 | P15151 | |
| LMRRALAVLQIFAVS | 341 | Q96C34 | |
| RAQRAGSVRMRVFKQ | 116 | P59025 | |
| YLVRQRISRLGQRMS | 6 | Q16563 | |
| FVRQVGRYLTLAIRM | 281 | Q6NW40 | |
| MSRRIIVGTLQRTQR | 1 | Q8IWZ4 | |
| RIMGFVSRSQERRLL | 576 | P52630 | |
| SGFTQRRRMALGIVI | 61 | Q8WV83 | |
| RMRCILQDGRIFIGT | 16 | P63162 | |
| RRQMLVAAIVFISFG | 81 | Q8WV15 | |
| NRIRSLARNVFAGMI | 191 | Q86VH5 | |
| TAVAALIMDRAGRRL | 306 | Q9NY64 | |
| VLQSRTAKMRVGRFA | 1776 | P58107 | |
| FMGIFVRNRIGRQAV | 236 | Q15678 | |
| LRALSRFEGMRVVVN | 1311 | Q14524 | |
| LSRFEGMRVVVNALI | 1301 | Q15858 | |
| RMRCILQDGRIFIGT | 16 | P14678 | |
| RFLREGRLAVLMEAQ | 126 | Q9Y4R8 | |
| MAAAVGRLLRASVAR | 1 | P30048 | |
| FILVAILRMNSRKGR | 226 | Q8NGG5 | |
| ERARVLGTRALQIAM | 61 | P61218 | |
| RVYRRIGNVGIVMSL | 696 | Q8NEZ3 | |
| DRFMGVRIVAAILAI | 201 | Q8IY50 | |
| QEAAAVLMARLGVFR | 521 | Q15437 | |
| ALSRFEGMRVVVNAL | 1326 | P35498 | |
| ARVVMITVSSARRRA | 821 | Q7Z7M1 | |
| VMRFERFGRRRVIIK | 131 | Q96M20 | |
| VGAVVFAVRSRRSMN | 161 | Q8TAZ6 | |
| FGMRTQVTREAISRL | 211 | Q6S5L8 | |
| VTVMVRSILLRGFDQ | 366 | Q16881 | |
| VLVVHGRASRQLQRM | 331 | Q86Y38 | |
| MVIVKEFQRNRSGRL | 321 | Q9H2G4 | |
| VPSFLVERMANVRRR | 151 | Q9NXB0 | |
| STRADGAMRRRVFVV | 341 | Q9H7N4 | |
| FLRIDGVLIRMNDTR | 186 | O75663 | |
| MSFRKGERITLLRQV | 886 | Q9BX66 | |
| QRGRFRAMVELARLD | 956 | P35916 | |
| ALSRFEGMRVVVNAL | 1316 | Q99250 | |
| ALSRFEGMRVVVNAL | 1306 | Q9UQD0 | |
| DGMIVSRRALGFLVR | 1421 | Q86X10 | |
| VEVFGVIRSLMAFRL | 56 | Q15393 | |
| VLMENFRRAIGLRIK | 111 | Q9Y265 | |
| MGVQVVGRAFARALR | 11 | Q9Y3D7 | |
| QIMEAVLGRRVGSLR | 221 | O15195 | |
| QSAGRLMRAIFEIVL | 1086 | O75643 | |
| QVRLFDMSGVRLARL | 431 | Q9Y2I8 | |
| MSETLIRNILFGAVR | 156 | Q9C0K7 | |
| FLLRGDVVLRAQMIR | 166 | A6NCK2 | |
| MVANRGEIAIRVFRA | 41 | P11498 | |
| VRRLMNISSVGRFLS | 281 | Q8N8C0 | |
| GFVAVILMRVLRNDL | 251 | O15321 | |
| GRREEAIAVTMRFLR | 1416 | O95071 | |
| AIAVTMRFLRSVARV | 1421 | O95071 | |
| MRFLRSVARVFVILS | 1426 | O95071 | |
| QAMSFAILRIIRLVR | 436 | P22459 | |
| ASIIQRGERLHMFRV | 5166 | O14686 | |
| GMNSFLIFARRIDIR | 1046 | O75096 | |
| VREVFARQLMQVRGV | 471 | Q96NY9 | |
| RRAAVVIQAFTRAMF | 836 | Q9ULV0 | |
| LTVQAYARGMIARRL | 841 | Q13402 | |
| RRAVVVIQAHARGMA | 856 | Q6PIF6 | |
| AIRAMAVLREAGRLR | 691 | Q13459 | |
| ASVLRNTKGRVRFMI | 566 | Q96SB3 |